Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Medical Letter (formerly Wescott Professional Publications) is a nonprofit organization that provides healthcare professionals with evidence-based, peer-reviewed evaluations of drug therapies. The company is best known for its flagship publication, 'The Medical Letter on Drugs and Therapeutics,' which offers unbiased analysis of new drugs and comparative reviews of older treatments. Its mission is to provide practitioners with the information they need to make informed prescribing decisions, strictly maintaining independence by refusing pharmaceutical industry advertising or grants. The organization also produces 'Treatment Guidelines from The Medical Letter' and various continuing medical education (CME) materials. All content is authored by a panel of experts and undergoes extensive external review to ensure clinical accuracy and objectivity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wescott Professional Publications.